1. Akizawa, T., Kitaoka, T., Sato, M., Koshikawa, S., Hirasawa, Y., Kazama, M., Mimura, N. and Ota, K. (1988) Comparative Clinical Trial of Regional Anticoagulation for Hemodialysis. ASAIO Transactions, 34,176-178.
2. Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study
3. Tsukagoshi, S. (2000) Pharmacokinetics Studies of Nafamostat Mesilate (FUT), a Synthetic Protease Inhibitor, Which Has Been Used for the Treatments of DIC and Acute Pancreatitis, and as an Anticoagulant in Extracorporeal Circulation. Japanese Journal of Cancer and Chemotherapy, 27, 767-774.
4. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation
5. Continuous renal replacement therapies: An update